Kerecis
Ísafjörður
About Kerecis
Kerecis develops patented fish-skin products to heal the human body. Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal substitute for human skin. More than 50 studies have been done on Kerecis technology. Those studies include two double-blind, comparative, randomized control trials, where fish skin treatment was more efficacious than mammalian-based treatments. Kerecis is also developing products for areas such as oral surgery, plastic surgery, and neurological applications. The company's products utilize multiple patented fish-skin and fatty-acid technologies to protect and regenerate tissue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $1K – $10K
- Total funding: $123.6M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2022)
- Website: kerecis.com
- Phone: +1-703-287-8752
Industries & Categories
Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/kerecis-44647 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.